D529-0275 Screening compound: ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate

D529-0275 Screening compound: ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
D529-0275 Screening compound: ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound D529-0275
ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D529-0275

Molecular Formula

C23H21F2N5O3 (C23 H21 F2 N5 O3)

Compound Name

ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate

IUPAC name

ethyl 7-(4-fluorophenyl)-4-{[(3-fluorophenyl)carbamoyl]methyl}-5-methyl-4H7H-[124]triazolo[15-a]pyrimidine-6-carboxylate

SMILES

CCOC(C1=C(C)N(CC(Nc2cccc(F)c2)=O)c2ncnn2C1c(cc1)ccc1F)=O

InChI

InChI=1S/C23H21F2N5O3/c1-3-33-22(32)20-14(2)29(12-19(31)28-18-6-4-5-17(25)11-18)23-26-13-27-30(23)21(20)15-7-9-16(24)10-8-15/h4-11,13,21H,3,12H2,1-2H3,(H,28,31)/t21-/m1/s1

InChI Key

OBKIKYWKFBGIJT-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD27591371

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.896

Distribution Coefficient, logD

3.896

Water Solubility, LogSw

-3.84

Polar Surface Area

70.124

Acid Dissociation Constant (pKa)

10.70

Base Dissociation Constant (pKb)

-0.36

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

21.70

D529-0275 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with D529-0275 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D529-0275?
Check Price and Availability of D529-0275, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D529-0275 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D529-0275
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D529-0275
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D529-0275 available by request